LifeStance Health Group, Inc. (LFST)
Stock analysis · NASDAQ · Healthcare · Medical - Care Facilities
LifeStance Health Group, Inc. (LFST) is a publicly traded company in the Healthcare sector. Latest price: $13.10. Market cap $5.01B. Trailing PE 100.61. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →You have viewed 7 SEO analysis pages
Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.
Continue with free signup1-Year Price
Earnings
Proprietary Signals
About LifeStance Health Group, Inc.
LifeStance Health Group, Inc. specializes in delivering outpatient mental healthcare services through its subsidiary network. The company offers a comprehensive array of mental health solutions, encompassing psychiatric evaluations and treatment, specialized psychological and neuropsychological testing, and diverse therapeutic modalities including individual, family, and group therapy sessions. The organization addresses a wide spectrum of mental health conditions, ranging from common issues like anxiety and depression to more complex challenges such as bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. Patients have access to care through various channels: virtually via its online platform or in-person at its many centers located throughout 32 states. LifeStance is dedicated to supporting individuals across all age groups, providing care for children, adolescents, adults, and the elderly. LifeStance Health Group, Inc. was founded in 2017 and its main offices are situated in Scottsdale, Arizona.
Valuation
| P/E (TTM) | 100.61× |
|---|---|
| P/S (TTM) | 3.16× |
| P/B | 3.40× |
| PEG | 0.04× |
| P/FCF (TTM) | 23.84× |
| EV / EBITDA | 37.83× |
| EV / Sales | 3.14× |
| Earnings Yield | 1.01% |
| Free Cash Flow Yield | 4.20% |
Fundamentals
| Enterprise Value | $4.98B |
|---|---|
| Revenue (TTM) | $1.58B |
| Net Income (TTM) | $50.42M |
| Free Cash Flow (TTM) | $217.67M |
| Net Debt | -$25.28M |
| Working Capital | $103.21M |
| Gross Margin | 33.56% |
| Operating Margin | 4.95% |
| Net Margin | 3.19% |
| Return on Equity | 3.39% |
| Return on Invested Capital | 3.03% |
Peers
Recent News
- LifeStance to Host Third Quarter 2026 Earnings Conference Call on November 5, 2026
- Take the Zacks Approach to Beat the Markets: HF Sinclair, Accenture & FirstCash in Focus
- Nearly Half of Americans Say Fear of an Unwanted Viral Moment Keeps Them from Being Themselves in Public, LifeStance Survey Finds
- LifeStance Health CTO Sells 42,067 Shares for $541,402
- 74,169 Shares in LifeStance Health Group, Inc. $LFST Bought by HighTower Advisors LLC
Related
Browse more tickers: sitemap